Page last updated: 2024-11-04

4'-bromoflavone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4'-bromoflavone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID1686
CHEMBL ID294099
SCHEMBL ID103839
MeSH IDM0301170

Synonyms (36)

Synonym
20525-20-6
AC-13516
CBMICRO_039679
4'-bromo-flavone
AKOS002389030
5973-70-6
2-(4-bromophenyl)-4h-1-benzopyran-4-one
4'-bromoflavone
BIM-0039592.P001
CHEMBL294099
4-bromoflavone
A73 ,
2-(4-bromophenyl)-4h-chromen-4-one
FT-0663741
2-(4-bromophenyl)chromen-4-one
4h-1-benzopyran-4-one, 2-(4-bromophenyl)-
flavone, 4'-bromo-
6tc8h54c8t ,
unii-6tc8h54c8t
4h-1-benzopyran-4-one,2-(4-bromophenyl)-
4KZU
bdbm150762
2-(4-bromophenyl)-4h-chromen-4-one (3n)
SCHEMBL103839
URZUAHXELZUWFE-UHFFFAOYSA-N
2-(4-bromophenyl)-4h-chromen-4-one #
bromoflavone, 4'-
DTXSID60174519
J-004701
J-013382
CS-0255619
Q27265495
HY-115772
4 inverted exclamation marka-bromoflavone
4'bf
4'-bromo-2-phenylbenzopyran

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)IC50 (µMol)0.31460.00190.62935.0000AID774398
Amine oxidase [flavin-containing] AHomo sapiens (human)Ki1.26000.00192.379710.0000AID1801003
Amine oxidase [flavin-containing] BHomo sapiens (human)Ki1.26000.00061.777110.0000AID1801003
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
NADHomo sapiens (human)CD0.01000.01000.07730.2100AID1315551
Quinone oxidoreductaseMus musculus (house mouse)Activity166.67430.02301.90249.9100AID380748; AID380757; AID380760
Quinone oxidoreductaseMus musculus (house mouse)CD19.20000.20002.74219.8000AID1354406
NAD(P)H dehydrogenase [quinone] 1Mus musculus (house mouse)CD0.01260.00020.23892.6500AID1182051; AID1237289; AID1372213; AID1379242; AID488653; AID630246; AID650846; AID719275; AID772982
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (91)

Processvia Protein(s)Taxonomy
peptidyl-serine phosphorylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
peptidyl-threonine phosphorylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein polyubiquitinationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
mitotic spindle organizationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein transportPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
Wnt signaling pathwayPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
regulation of telomere maintenance via telomerasePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of telomere maintenance via telomerasePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
mRNA transportPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
spindle assemblyPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
cell divisionPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of telomerase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein localization to chromosome, telomeric regionPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein poly-ADP-ribosylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein auto-ADP-ribosylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of canonical Wnt signaling pathwayPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of telomere cappingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
negative regulation of telomere maintenance via telomere lengtheningPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
negative regulation of telomeric DNA bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
negative regulation of maintenance of mitotic sister chromatid cohesion, telomericPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
protein polyubiquitinationNADHomo sapiens (human)
response to ischemiaNADHomo sapiens (human)
NADH oxidationNADHomo sapiens (human)
ubiquinone metabolic processNADHomo sapiens (human)
xenobiotic metabolic processNADHomo sapiens (human)
nitric oxide biosynthetic processNADHomo sapiens (human)
response to oxidative stressNADHomo sapiens (human)
synaptic transmission, cholinergicNADHomo sapiens (human)
response to nutrientNADHomo sapiens (human)
response to toxic substanceNADHomo sapiens (human)
response to hormoneNADHomo sapiens (human)
response to carbohydrateNADHomo sapiens (human)
response to amineNADHomo sapiens (human)
removal of superoxide radicalsNADHomo sapiens (human)
protein catabolic processNADHomo sapiens (human)
response to estradiolNADHomo sapiens (human)
response to lipopolysaccharideNADHomo sapiens (human)
response to testosteroneNADHomo sapiens (human)
cellular response to oxidative stressNADHomo sapiens (human)
negative regulation of protein catabolic processNADHomo sapiens (human)
vitamin E metabolic processNADHomo sapiens (human)
vitamin K metabolic processNADHomo sapiens (human)
negative regulation of apoptotic processNADHomo sapiens (human)
response to alkaloidNADHomo sapiens (human)
positive regulation of neuron apoptotic processNADHomo sapiens (human)
innate immune responseNADHomo sapiens (human)
cell redox homeostasisNADHomo sapiens (human)
response to ethanolNADHomo sapiens (human)
response to electrical stimulusNADHomo sapiens (human)
cellular response to hydrogen peroxideNADHomo sapiens (human)
NADPH oxidationNADHomo sapiens (human)
cellular response to metal ionNADHomo sapiens (human)
negative regulation of ferroptosisNADHomo sapiens (human)
response to tetrachloromethaneNADHomo sapiens (human)
response to L-glutamineNADHomo sapiens (human)
response to hydrogen sulfideNADHomo sapiens (human)
response to flavonoidNADHomo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
NAD+ ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
zinc ion bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleotidyltransferase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
histone bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
RNA bindingNADHomo sapiens (human)
cytochrome-b5 reductase activity, acting on NAD(P)HNADHomo sapiens (human)
superoxide dismutase activityNADHomo sapiens (human)
protein bindingNADHomo sapiens (human)
NADPH dehydrogenase (quinone) activityNADHomo sapiens (human)
identical protein bindingNADHomo sapiens (human)
NADH:ubiquinone reductase (non-electrogenic) activityNADHomo sapiens (human)
NAD(P)H dehydrogenase (quinone) activityNADHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
Golgi membranePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
pericentriolar materialPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
chromosome, telomeric regionPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleoplasmPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
Golgi apparatusPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
cytosolPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nuclear bodyPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nuclear membranePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
mitotic spindle polePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nuclear porePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
cytoplasmPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
nucleusNADHomo sapiens (human)
cytoplasmNADHomo sapiens (human)
cytosolNADHomo sapiens (human)
dendriteNADHomo sapiens (human)
neuronal cell bodyNADHomo sapiens (human)
synapseNADHomo sapiens (human)
cytosolNADHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (60)

Assay IDTitleYearJournalArticle
AID1285390Induction of quinone reductase specific activity in mouse mutant BpRc1 cells expressing defective translocator receptor Arnt using 2,6-DCIP as substrate at 10 uM measured for 1 min relative to control2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID513961Induction glutathione-CYP1A1 in rat liver at 15 mg/kg, po qd by EROD assay2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID1379240Estrogenic activity at estrogen receptor alpha in human Ishikawa cells assessed as induction of alkaline phosphatase activity using p-Nitrophenol phosphate as substrate pretreated for 96 hrs followed by substrate addition measured every 15 secs by scannin2017Journal of natural products, 08-25, Volume: 80, Issue:8
DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health.
AID1267473Cytotoxicity against mouse Hepa-1c1c7 cells assessed as cell viability at 10 uM after 24 hrs by crystal violet staining-based assay2016Bioorganic & medicinal chemistry letters, Jan-01, Volume: 26, Issue:1
Bioactive minor components of the total salvianolic acids injection prepared from Salvia miltiorrhiza Bge.
AID295385Growth inhibition of HT29 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID513959Cytotoxicity against human HT-29 cells2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID1860353Inhibition of CYP450 in human liver microsomes assessed as inhibition of 20-HETE formation at 10 uM in presence of arachidonic acid and NADPH by multi-enzyme assay based LC-MS/MS analysis relative to control
AID1354408Cytotoxicity against HEK293 cells assessed as reduction in cell viability by CMFDA dye based fluorescence assay
AID380758Inhibition of mouse Hepa-1c1c7 Bprc1 mutant cells assessed as cell viability2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID1315551Induction of quinone reductase-1 in human Hepa-1c1c7 cells assessed as reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide after 48 hrs by crystal violet staining-based assay2016Journal of natural products, 06-24, Volume: 79, Issue:6
Anti-inflammatory and Quinone Reductase Inducing Compounds from Fermented Noni (Morinda citrifolia) Juice Exudates.
AID776774Aqueous solubility of the compound2013European journal of medicinal chemistry, Nov, Volume: 69Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds.
AID488653Induction of NADPH-dependent quinone reductase activity in mouse Hepa-1c1c7 cells assessed as concentration to double activity after 48 hrs by MTT assay2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Fijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus Nocardiopsis.
AID1237289Activation of Quinone reductase-1 in mouse Hepa-1c1c7 cells assessed as concentration required to double enzyme activity after 48 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Aug-01, Volume: 25, Issue:15
Synthesis, molecular docking and anticancer studies of peptides and iso-peptides.
AID513956Induction of quinone reductase activity in rat liver at 15 mg/kg, po qd2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID1285389Induction of quinone reductase specific activity in mouse Hepa1c1c7 cells using 2,6-DCIP as substrate at 10 uM measured for 1 min relative to control2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID380752Induction of antioxidant response element activity in human HepG2 cells at 10 uM by luciferase based chemiluminescence assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID380495Induction of ARE in human HepG2 cells by luciferase assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Bioactive dammarane triterpenes from the mangrove plant Bruguiera gymnorrhiza.
AID1192791Cytotoxicity against mouse Hepa-1c1c7 cells assessed as cell viability at 10 uM after 10 mins2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Chemopreventive flavonoids from Millettia pulchra Kurz var-laxior (Dunn) Z.Wei (Yulangsan) function as Michael reaction acceptors.
AID776775Antiplasmodial activity against chloroquine-resistant blood stage of Plasmodium falciparum W2 infected in human RBC after 48 hrs by flow cytometric analysis2013European journal of medicinal chemistry, Nov, Volume: 69Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds.
AID295386Growth inhibition of HK2 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID380757Induction of NADPH:quinone reductase activity in mouse Hepa-1c1c7 Bprc1 mutant cells assessed as drug level required to double specific enzyme activity2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID380748Induction of NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells assessed as drug level required to double specific enzyme activity2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID295382Cytotoxicity against human HT29 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID774398Inhibition of human TNKS1 (1030 to 1317) using NAD+ as substrate by fluorescence assay2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.
AID1379243Cytotoxicity against mouse Hepa1c1c7 cells after 48 hrs by crystal violet staining based assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health.
AID513957Cytotoxicity against human MCF7 cells2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID772982Induction of quinone reductase-1 activity in mouse Hepa-1c1c7 cells assessed as concentration required to double induction activity by MTT assay2013European journal of medicinal chemistry, Oct, Volume: 68Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
AID513960Induction glutathione-S-transferase activity in rat liver at 15 mg/kg, po qd2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID1192789Induction of NQO1 activity in mouse Hepa-1c1c7 cells assessed as induction ratio at 10 uM after 48 hr by NADPH-dependent MTT assay relative to control2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Chemopreventive flavonoids from Millettia pulchra Kurz var-laxior (Dunn) Z.Wei (Yulangsan) function as Michael reaction acceptors.
AID1379241Cytotoxicity against human Ishikawa cells after 96 hrs by SRB assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health.
AID1860355Selectivity index, log ratio of Inhibition of CYP450 in human liver microsomes assessed as inhibition of EpETrE formation in presence of arachidonic acid to Inhibition of CYP450 in human liver microsomes assessed as inhibition of 20-HETE formation in pres
AID1285397Chemoprotective index, ratio of IC50 for mouse mutant BpRc1 cells to CD for quinone reductase activity in mouse mutant BpRc1 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1285398Ratio of induction of quinone reductase specific activity in mouse mutant BpRc1 cells to mouse Hepa1c1c7 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID513958Cytotoxicity against human TK10 cells2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID1285394Chemoprotective index, ratio of IC50 for mouse Hepa1c1c7 cells to CD for quinone reductase activity in mouse Hepa1c1c7 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1372213Induction of QR1 activity in mouse Hepa-1c1c7 cells assessed as drug concentration required to double enzyme activity after 48 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 12-15, Volume: 27, Issue:24
Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
AID1860354Inhibition of CYP450 in human liver microsomes assessed as inhibition of EpETrE formation at 10 uM in presence of arachidonic acid and NADPH by multi-enzyme assay based LC-MS/MS analysis relative to control
AID295381Cytotoxicity against human MCF7 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID1267470Induction of NQO1 activity in mouse Hepa-1c1c7 cells at 10 uM after 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry letters, Jan-01, Volume: 26, Issue:1
Bioactive minor components of the total salvianolic acids injection prepared from Salvia miltiorrhiza Bge.
AID772983Induction of quinone reductase-1 activity in mouse Hepa-1c1c7 cells assessed as induction ratio at 50 uM by MTT assay relative to DMSO-treated control2013European journal of medicinal chemistry, Oct, Volume: 68Chemopreventive and antioxidant activity of 6-substituted imidazo[2,1-b]thiazoles.
AID1354406Induction of quinone reductase activity in mouse Hepa1c1c7 cells using menadiol/NADPH as substrate after 48 hrs by MTT assay
AID1285391Ratio of quinone reductase specific activity in mouse Hepa1c1c7 cells to quinone reductase specific activity in mouse mutant BpRc1 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID295384Growth inhibition of MCF7 cells by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID380760Induction of NADPH:quinone reductase activity in mouse Hepa-1c1c7 TAOc1Bprc1 mutant cells assessed as drug level required to double specific enzyme activity2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID650846Induction of QR1 in mouse Hepa-1c1c7 cells assessed as concentration required to double QR1 induction by MTT assay2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
AID1285396Induction of quinone reductase activity in mouse mutant BpRc1 cells using 2,6-DCIP as substrate measured for 1 min2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID380750Inhibition of mouse Hepa-1c1c7 cells assessed as cell viability2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID1182051Induction of quinone reductase 1 in mouse Hepa-1c1c7 cells after 48 hrs by MTT assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Spongiapyridine and related spongians isolated from an Indonesian Spongia sp.
AID1285392Cytotoxicity against mouse Hepa1c1c7 cells after 48 hrs by SRB assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID719275Induction of quinone reductase-1 activity in mouse Hepa-1c1c7 cells after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).
AID1285395Cytotoxicity against mouse mutant BpRc1 cells after 48 hrs by SRB assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID513978Toxicity in Sprague-Dawley rat assessed as change in body weight at 250 mg/kg, po2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
AID295380Cytotoxicity against human TK10 cells in aerobic condition assessed as survival at 100 uM by sulforhodamine assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships.
AID380761Inhibition of mouse Hepa-1c1c7 TAOc1Bprc1 mutant cells assessed as cell viability2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID630246Induction of quinone reductase 1 in mouse Hepa 1c1c7 cells assessed as concentration of compound required to double enzyme activity by MTT assay2011Bioorganic & medicinal chemistry, Nov-01, Volume: 19, Issue:21
Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents.
AID380749Chemoprevention index, ratio of IC50 for mouse Hepa-1c1c7 cells to drug level required to double specific NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells2006Journal of natural products, Mar, Volume: 69, Issue:3
Quinone reductase induction as a biomarker for cancer chemoprevention.
AID1285393Induction of quinone reductase specific activity in mouse Hepa1c1c7 cells assessed as concentration required to double enzyme specific activity using 2,6-DCIP as substrate measured for 1 min2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1379242Induction of NQO1 activity in mouse Hepa1c1c7 cells after 48 hrs by MTT reduction assay2017Journal of natural products, 08-25, Volume: 80, Issue:8
DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women's Health.
AID1801003Fluorimetric Assay from Article 10.1016/j.bioorg.2014.11.008: \\Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.\\2015Bioorganic chemistry, Feb, Volume: 58Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.17)18.2507
2000's4 (16.67)29.6817
2010's18 (75.00)24.3611
2020's1 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.27 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]